Hello. Sign in to personalize your visit. New user? Register now.  
Human Gene Therapy
Serotype Specificity of Adenovirus Purification Using Anion-Exchange Chromatography

To cite this article:
John O. Konz, Rebecca C. Livingood, Andrew J. Bett, Aaron R. Goerke, Michael E. Laska, Sangeetha L. Sagar. Human Gene Therapy. November 2005, 16(11): 1346-1353. doi:10.1089/hum.2005.16.1346.

Full Text: • PDF for printing (265.1 KB) • PDF w/ links (305.5 KB)


Dr. John O. Konz
Biologics Development and Engineering, Merck Research Laboratories, West Point, PA 19486.
Rebecca C. Livingood
Biologics Development and Engineering, Merck Research Laboratories, West Point, PA 19486.
Andrew J. Bett
Vaccine and Biologics Research, Merck Research Laboratories, West Point, PA 19486.
Aaron R. Goerke
Biologics Development and Engineering, Merck Research Laboratories, West Point, PA 19486.
Michael E. Laska
Biologics Development and Engineering, Merck Research Laboratories, West Point, PA 19486.
Sangeetha L. Sagar
Biologics Development and Engineering, Merck Research Laboratories, West Point, PA 19486.

Recombinant adenoviruses continue to be a leading vector choice for gene transfer applications, with growing interest in the use of less prevalent serotypes, and of chimeras. As a result, the development of scaleable purification processes for alternative serotypes is needed. Anion-exchange chromatography is routinely used for scaleable adenovirus type 5 purification; however, retention varies for other serotypes because of differences in the exposed capsid proteins. Understanding how the viral surface influences retention behavior can provide a rational basis for chromatography development and optimization. In this work, chimeric vectors were used to show that the hexon protein is responsible for retention differences in anion-exchange chromatography. Next, the relative retention of eight serotypes from three subgroups was studied. Although all serotypes bound to the anion-exchange resin, the sodium chloride required to elute the virus varied over a 2- fold range, from 270 to 490 mM. Retention was accurately correlated to the electrostatic properties of the hexon protein, with an average error in sodium chloride concentration required to elute of only 14 mM. This correlation enables preparative chromatography gradients for alternative serotypes to be established with minimal effort.

Free first page

This paper was cited by:

Understanding the mechanism of virus removal by Q sepharose fast flow chromatography during the purification of CHO-cell derived biotherapeutics
Daniel M. Strauss, Scott Lute, Zinaida Tebaykina, Douglas D. Frey, Cintia Ho, Gregory S. Blank, Kurt Brorson, Qi Chen, Bin Yang
Biotechnology and Bioengineering. Feb 2009: n/a-n/a
CrossRef
Flow-dependent entrapment of large bioparticles in porous process media
Egor I. Trilisky, Abraham M. Lenhoff
Biotechnology and Bioengineering. Feb 2009: n/a-n/a
CrossRef
Anion exchange chromatography provides a robust, predictable process to ensure viral safety of biotechnology products
Daniel M. Strauss, Jeffrey Gorrell, Magdalena Plancarte, Gregory S. Blank, Qi Chen, Bin Yang
Biotechnology and Bioengineering. Feb 2009, Vol. 102, No. 1: 168-175
CrossRef
Towards purification of adenoviral vectors based on membrane technology
Cristina Peixoto, Tiago B. Ferreira, Marcos F. Q. Sousa, Manuel J. T. Carrondo, Paula M. Alves
Biotechnology Progress. Dec 2008, Vol. 24, No. 6: 1290-1296
CrossRef
All articles
Previous Next